258 related articles for article (PubMed ID: 26201690)
1. ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling.
Koren L; Alishekevitz D; Elhanani O; Nevelsky A; Hai T; Kehat I; Shaked Y; Aronheim A
Int J Cardiol; 2015 Nov; 198():232-40. PubMed ID: 26201690
[TBL] [Abstract][Full Text] [Related]
2. The cardiac maladaptive ATF3-dependent cross-talk between cardiomyocytes and macrophages is mediated by the IFNγ-CXCL10-CXCR3 axis.
Koren L; Barash U; Zohar Y; Karin N; Aronheim A
Int J Cardiol; 2017 Feb; 228():394-400. PubMed ID: 27870968
[TBL] [Abstract][Full Text] [Related]
3. ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.
Kalfon R; Koren L; Aviram S; Schwartz O; Hai T; Aronheim A
Cardiovasc Res; 2017 Feb; 113(2):134-146. PubMed ID: 28082453
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic and puzzling effects of ATF3 in maladaptive cardiac remodeling.
Zhou H; Yuan Y; Ni J; Guo H; Deng W; Bian ZY; Tang QZ
Int J Cardiol; 2016 Mar; 206():87-8. PubMed ID: 26780683
[No Abstract] [Full Text] [Related]
5. ATF3: A potential target for cardiac maladaptive remodeling.
Ma ZG; Wei WY; Xu SC; Zhang WB; Dai J; Tang QZ
Int J Cardiol; 2016 Jan; 202():50-1. PubMed ID: 26386920
[No Abstract] [Full Text] [Related]
6. Response letter: "ATF3: A promoter or inhibitor of cardiac maladaptive remodeling".
Koren L; Shaked Y; Aronheim A
Int J Cardiol; 2015 Dec; 201():692. PubMed ID: 26374759
[No Abstract] [Full Text] [Related]
7. JDP2 and ATF3 deficiencies dampen maladaptive cardiac remodeling and preserve cardiac function.
Kalfon R; Friedman T; Eliachar S; Shofti R; Haas T; Koren L; Moskovitz JD; Hai T; Aronheim A
PLoS One; 2019; 14(2):e0213081. PubMed ID: 30818334
[TBL] [Abstract][Full Text] [Related]
8. ATF3: A promotion effect or a inhibition effect in cardiac maladaptive remodeling.
Yang J; Yang CJ; Yang J; Fan ZX
Int J Cardiol; 2015 Dec; 201():245-6. PubMed ID: 26301647
[No Abstract] [Full Text] [Related]
9. Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload.
Zhou H; Shen DF; Bian ZY; Zong J; Deng W; Zhang Y; Guo YY; Li H; Tang QZ
PLoS One; 2011; 6(10):e26744. PubMed ID: 22053207
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
11. Activating transcription factor 3 protects against pressure-overload heart failure via the autophagy molecule Beclin-1 pathway.
Lin H; Li HF; Chen HH; Lai PF; Juan SH; Chen JJ; Cheng CF
Mol Pharmacol; 2014 May; 85(5):682-91. PubMed ID: 24550138
[TBL] [Abstract][Full Text] [Related]
12. Pressure overload inhibits glucocorticoid receptor transcriptional activity in cardiomyocytes and promotes pathological cardiac hypertrophy.
Matsuhashi T; Endo J; Katsumata Y; Yamamoto T; Shimizu N; Yoshikawa N; Kataoka M; Isobe S; Moriyama H; Goto S; Fukuda K; Tanaka H; Sano M
J Mol Cell Cardiol; 2019 May; 130():122-130. PubMed ID: 30946837
[TBL] [Abstract][Full Text] [Related]
13. Adult cardiac expression of the activating transcription factor 3, ATF3, promotes ventricular hypertrophy.
Koren L; Elhanani O; Kehat I; Hai T; Aronheim A
PLoS One; 2013; 8(7):e68396. PubMed ID: 23874609
[TBL] [Abstract][Full Text] [Related]
14. Macrophage microRNA-155 promotes cardiac hypertrophy and failure.
Heymans S; Corsten MF; Verhesen W; Carai P; van Leeuwen RE; Custers K; Peters T; Hazebroek M; Stöger L; Wijnands E; Janssen BJ; Creemers EE; Pinto YM; Grimm D; Schürmann N; Vigorito E; Thum T; Stassen F; Yin X; Mayr M; de Windt LJ; Lutgens E; Wouters K; de Winther MP; Zacchigna S; Giacca M; van Bilsen M; Papageorgiou AP; Schroen B
Circulation; 2013 Sep; 128(13):1420-32. PubMed ID: 23956210
[TBL] [Abstract][Full Text] [Related]
15. Induction of activating transcription factor 3 limits survival following infarct-induced heart failure in mice.
Brooks AC; DeMartino AM; Brainard RE; Brittian KR; Bhatnagar A; Jones SP
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1326-35. PubMed ID: 26342068
[TBL] [Abstract][Full Text] [Related]
16. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
Li Y; Li Z; Zhang C; Li P; Wu Y; Wang C; Bond Lau W; Ma XL; Du J
Circulation; 2017 May; 135(21):2041-2057. PubMed ID: 28249877
[TBL] [Abstract][Full Text] [Related]
19. Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice.
Zou Y; Li J; Ma H; Jiang H; Yuan J; Gong H; Liang Y; Guan A; Wu J; Li L; Zhou N; Niu Y; Sun A; Nakai A; Wang P; Takano H; Komuro I; Ge J
J Mol Cell Cardiol; 2011 Nov; 51(5):821-9. PubMed ID: 21854784
[TBL] [Abstract][Full Text] [Related]
20. SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.
Wu G; Liu Y; Huang H; Tang Y; Liu W; Mei Y; Wan N; Liu X; Huang C
Cardiovasc Res; 2015 Jul; 107(2):203-15. PubMed ID: 26077624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
